[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368034-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368034-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","global-disparities-and-temporal-trends-in-prostate-bladder-and-kidney-cancer-burden-among-men-a-systematic-analysis-of-204-countries-1990-2021","Global Disparities and Temporal Trends in Prostate, Bladder, and Kidney Cancer Burden Among Men - A Systematic Analysis of 204 Countries (1990-2021)","","Urological cancers—especially prostate, bladder, and kidney cancers—remain an expanding public health challenge for men. High-income settings have improved early detection and outcomes, while many low- and middle-income countries experience late diagnosis and constrained resources. Using Global Burden of Disease 2021 data (1990–2021) across 204 countries, the study evaluates age-standardized incidence, mortality, and DALYs trends with EAPC, risk attribution by SDI, and uncertainty intervals from posterior simulations.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/global-disparities-and-temporal-trends-in-prostate-bladder-and-kidney-cancer-burden-among-men-a-systematic-analysis-of-204-countries-1990-2021/368034/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/global-disparities-and-temporal-trends-in-prostate-bladder-and-kidney-cancer-burden-among-men-a-systematic-analysis-of-204-countries-1990-2021/368034.png","ImageObject",300,407,{"name":42,"@type":43},"LangkahRina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What data and methods were used to analyze cancer trends from 1990 to 2021?","Question",{"text":63,"@type":64},"The analysis used Global Burden of Disease Study 2021 data across 204 countries, assessing age-standardized incidence (ASIR), mortality (ASMR), and DALYs. Temporal trends were evaluated with EAPC, with risk attribution based on GBD comparative risk assessment and uncertainty intervals from 1000 posterior simulations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did prostate cancer incidence and mortality change globally?",{"text":68,"@type":64},"Prostate cancer ASIR showed minimal change globally, while ASMR declined significantly. The study reports the highest incidence in North America alongside notable mortality reduction, while Eastern Europe and sub-Saharan Africa saw rising mortality despite lower incidence.",{"name":70,"@type":61,"acceptedAnswer":71},"Which risk factors and geographic patterns were identified for these urological cancers?",{"text":72,"@type":64},"Major risk factors included tobacco use, occupational exposures such as trichloroethylene, and metabolic conditions like obesity and hypertension. High SDI regions benefited from earlier screening and targeted therapies, whereas LMICs carried a heavier DALYs burden due to late-stage diagnoses and limited care.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368034,1790218117,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","| Global Disparities and Temporal Trends in Prostate, Bladder, and Kidney Cancer Burden Among Men: A Systematic Analysis of\u003Cbr>204 Countries (1990-2021) | Cancer Control Volume 32: 1-18 © The Author(s) 2025 Article reuse guidelines:\u003Cbr>[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/10732748251411011](DOI: 10.1177/10732748251411011)\u003Cbr>[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)\u003Cbr>\u003Cbr>|\n| --- | --- |\n| Zidian Hu, MD 1,2,3, Ding Zeng, MD4, Xu Zhao, MD3, Yuanyuan Luo, MD 1,2,3,\u003Cbr>Zhengnan Li, MD3, Wanxiang You, MD3, Junjie Zhao, MD3, Shiwei Xiao, MD3, Bo Yu, PhD3, Hao Su, MD2,3, Dongbo Yuan, PhD 1,2,3, Jianguo Zhu, PhD 1,2,3, and Bo Yan, PhD 1,2,3 􀀁\u003Cbr>Abstract\u003Cbr>Introduction: Urological cancers—primarily prostate, bladder, and kidney cancers—pose a growing global public health challenge, particularly affecting men. While high-income countries have achieved early detection and better treatment outcomes, low-and middle-income countries (LMICs) continue to face late diagnoses and healthcare resource limitations. Methods: This study leveraged Global Burden of Disease Study 2021 (GBD 2021) data to assess trends in age-standardized incidence rates (ASIRs), age-standardized mortality rates (ASMRs), and disability-adjusted life years (DALYs) for the three major urological cancers among men across 204 countries from 1990 to 2021 . The ASIRs, ASMRs, and DALYs experienced the same age standardization. Estimated Annual Percentage Change (EAPC) was used to evaluate temporal trends. Risk attribution was examined using GBD’s comparative risk assessment framework and stratiﬁed by Sociodemographic Index (SDI) levels. Uncertainty intervals (UIs) were based on 1000 posterior simulations.\u003Cbr>Results: Globally, prostate cancer ASIRs showed minimal change (EAPC 􀀁0.06), while ASMRs declined signiﬁcantly (EAPC 􀀁1.05). North America had the highest incidence but notable mortality reduction, whereas Eastern Europe and subSaharan Africa experienced rising mortality despite lower incidence. Bladder cancer incidence declined worldwide (EAPC 􀀁0.35) but increased in Central Europe and Southeast Asia. Kidney cancer ASIRs rose globally (EAPC 0.72), with Mongolia showing the fastest increase (EAPC 16.22). Major risk factors included tobacco use, occupational exposures (eg, trichloroethylene), and metabolic conditions like obesity and hypertension. High SDI regions beneﬁted from early screening and targeted therapies, while LMICs bore a heavier DALYs burden due to late-stage diagnoses and limited care.\u003Cbr>Conclusion: Global progress in urological cancer detection and treatment is offset by widening disparities, particularly in LMICs. Addressing these inequities requires policies promoting equitable access to screening, risk factor reduction, and stronger cancer surveillance. Integrated, patient-centered strategies are crucial for achieving cancer control goals and reducing preventable deaths.\u003Cbr>Plain Language Summary\u003Cbr>Prostate, bladder, and kidney cancers are becoming increasingly common among men worldwide, posing a major health challenge—especially in low-and middle-income countries where access to early diagnosis and quality care is limited. Using |  |\n| 1 Medical School of Guizhou University, Guiyang City, China 2Guizhou University Afﬁliated People’s Hospital, Guiyang City, China 3Guizhou Provincial People’s Hospital, Guiyang, China\u003Cbr>4Guihang Pingba Hospital, Anshun City, China\u003Cbr>Corresponding Author:\u003Cbr>Bo Yan, Medical School of Guizhou University, No. 83 east Zhongshan road, Guiyang city 550001, Guizhou province, China.\u003Cbr>Email: [doctorbyhospital@163.com](doctorbyhospital@163.com) |  |\n\nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commerc","cbCaicM82HHkUAYP","https://ap.wps.com/l/cbCaicM82HHkUAYP","pdf",2958882,18,"English","# Abstract\n# Introduction\n# Methods\n# Results\n# Conclusion\n# Plain Language Summary\n# Keywords\n# Highlights\n# Received, Revised, and Accepted","[{\"question\":\"What data and methods were used to analyze cancer trends from 1990 to 2021?\",\"answer\":\"The analysis used Global Burden of Disease Study 2021 data across 204 countries, assessing age-standardized incidence (ASIR), mortality (ASMR), and DALYs. Temporal trends were evaluated with EAPC, with risk attribution based on GBD comparative risk assessment and uncertainty intervals from 1000 posterior simulations.\"},{\"question\":\"How did prostate cancer incidence and mortality change globally?\",\"answer\":\"Prostate cancer ASIR showed minimal change globally, while ASMR declined significantly. The study reports the highest incidence in North America alongside notable mortality reduction, while Eastern Europe and sub-Saharan Africa saw rising mortality despite lower incidence.\"},{\"question\":\"Which risk factors and geographic patterns were identified for these urological cancers?\",\"answer\":\"Major risk factors included tobacco use, occupational exposures such as trichloroethylene, and metabolic conditions like obesity and hypertension. High SDI regions benefited from earlier screening and targeted therapies, whereas LMICs carried a heavier DALYs burden due to late-stage diagnoses and limited care.\"}]","Global Disparities and Temporal Trends in Prostate, Bladder, and Kidney Cancer Burden Among Men - A Systematic Analysis of 204 Countries (1990-2021) | PDF",1790174518,45,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6044682f37d2ee2e729ba5d3f499c7da.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dfb679bd79ed8f4e4964c7bd36038c44.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b1605afd5d342e2e51720ce74a2079b.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a4487c27d5743d9e086b9c4befccda2.webp",980,1268]